Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial

Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:14:41.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a transition notice about using “Super Intelligence” in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-25T14:24:51.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T14:36:06.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1, while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:43:27.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Access to the study record has been replaced by a 403 Forbidden error page, effectively removing the study details and navigation from view. The page now shows a standard 403 message along with site chrome (Home link and footer).
    Difference
    21%
    Check dated 2026-09-20T20:32:02.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Related topics were added to the page, including a 'Multiple myeloma' entry and a MedlinePlus Genetics link, under the related topics section to aid navigation.
    Difference
    0.1%
    Check dated 2026-09-06T22:33:27.000Z thumbnail image

Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.